Various Psychiatric Manifestation in DiGeorge Syndrome (22q11.2 Deletion Syndrome): A Case Report

키워드

참고문헌 (20)

1. Shprintzen RJ, "Velo-cardio-facial syndrome", Curr Opin Pediatr, 17, pp.725~730 (2005)
2. Ryan AK, "Spectrum of clinical features associated with interstitial chromosome 22q11 deletions : a European collaborative study", J Med Genet, 34, pp.798~804 (1997)
3. McDonald-McGinn DM, "Chromosome 22q11.2deletion syndrome (DiGeorge syndrome", velocardiofacial syndrome), 2011, pp.90, 1~18
4. Scambler PJ, "Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus", Lancet, 339, pp.1138~1139 (1992)
5. Bassett AS, "Schizophrenia and 22q11.2 deletion syndrome", Curr Psychiatry Rep, 10, pp.148~157 (2008)
6. Schneider M, "Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome:results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome", Am J Psychiatry, 171, pp.627~639 (2014)
7. Cascella M, "Early onset intellectual disability in chromosome 22q11.2 deletion syndrome", Rev Chil Pediatr, 86, pp.283~286 (2015)
8. Kobrynski LJ, "Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes", Lancet, 370, pp.1443~1452 (2007)
9. Fusar-Poli P, "The psychosis high-risk state : a comprehensive state-of-the-art review", JAMA Psychiatry, 70, pp.107~120 (2013)
10. Schultze-Lutter F, "Revisiting the basic symptom concept : toward translating risk symptoms for psychosis into neurobiological targets", Front Psychiatry, 7, pp.9~ (2016)
11. Tastuzawa Y, "An interictal schizophrenia-like psychosis in an adult patient with 22q11.2 deletion syndrome", Epilepsy Behav Case Rep, 3, pp.36~38 (2015)
12. Boot E, "COMT Val(158)met genotype and striatal D(2", 3)receptor binding in adults with 22q11 deletion syndrome, 2011, pp.65, 967~970
13. Boot E, "Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome", Neuropsychopharmacology, 33, pp.1252~1258 (2008)
14. Bearden CE, "Effects of COMT genotype on behavioral symptomatology in the 22q11.2 deletion syndrome. 2 Deletion Syndrome", Child Neuropsychol, 11, pp.109~117 (2005)
15. Huang E, "Catechol-O-methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients:a meta-analysis", Int J Neuropsychopharmacol, 19, pp.pyv132~ (2016)
16. Zivković M, "The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol", J Clin Psychopharmacol, 33, pp.593~599 (2013)
17. Shirakawa T, "Neuronal expression of catechol O-methyltransferase mRNA in neonatal rat suprachiasmatic nucleus", Neuroreport, 15, pp.1239~1243 (2004)
18. Armbruster D, "Children under stress-COMT genotype and stressful life events predict cortisol increase in an acute social stress paradigm", Int J Neuropsychopharmacol, 15, pp.1229~1239 (2012)
19. So Yeon Kim, "Limbic Encephalitis Manifesting as Selective Amnesia and Seizure-like Activity: A Case Report", Clinical Psychopharmacology and Neuroscience, 16(1), pp.109~113 (2018), 대한정신약물학회[DOI]
20. Hande Gurbuz Aytuluk, "Can Propofol Lead to an Increase in Seizure Threshold Over the Course of Electroconvulsive Therapy?", Clinical Psychopharmacology and Neuroscience, 17(4), pp.523~530 (2019), 대한정신약물학회[DOI]

관련 논문AI추천